Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/4044
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOKPALA, I. E.-
dc.contributor.authorOLATUNJl, P. O.-
dc.contributor.authorOKUNADE, M. A.-
dc.contributor.authorOGUNSANWO, B. A.-
dc.contributor.authorJEJE, O. M.-
dc.contributor.authorSHOKUNBI, W. A.-
dc.contributor.authorESSIEN, E. M.-
dc.date.accessioned2025-05-08T12:37:19Z-
dc.date.available2025-05-08T12:37:19Z-
dc.date.issued1990-
dc.identifier.citationAfr J Med Med Sci 1990, 19(4):313-317en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/4044-
dc.descriptionArticleen_US
dc.description.abstractPatients with acute lymphoblastic leukaemia (ALL) seen in University College Hospital, Ibadan. Nigeria, still have low rates of complete remission and relatively short survival. Yet the overall prognosis was expected to have improved because the proportions of adults, males and people of low socio-economic class among the patients have decreased steadily over the past three decades. Possible causes of the persistent poor performance were sought for in 30 new ALL patients seen in the hospital over a period of 2 years and 9 months. Unfavourable prognostic factors, lack of standard cytotoxic drugs, inadequate supportive care and absence of modern facilities for therapy combined to make their disease outcome worse than expected.en_US
dc.description.sponsorshipCOLLEGE OF MEDICINE, UNIVERSITY OF IBADAN, NIGERIAen_US
dc.language.isoenen_US
dc.publisherCOLLEGE OF MEDICINE, UNIVERSITY OF IBADAN, NIGERIAen_US
dc.subjectacute lymphoblastic leukaemiaen_US
dc.subjectIbadanen_US
dc.titlePrognosis of acute lymphoblastic leukaemia in Ibadan, Nigeriaen_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Okpala et al_Prognosis_1990.pdfArticle1.12 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.